^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
LungCure™ CDx

Type:
Other Approval
Related tests:
Evidence

News

2years
Burning Rock secures second NGS kit approval from the NMPA (Burning Rock Dx Press Release)
"Burning Rock Biotech Limited...announced that the National Medical Products Administration (NMPA) approved Burning Rock’s Human Nine-Gene Mutation Joint Detection Kit (reversible termination sequencing) (LungCure™ CDx) as a class III medical device. This approval demonstrates Burning Rock's industry-leading capability of working with the NMPA on bringing an innovative next generation sequencing (NGS)-based diagnostic product to the China market."
Non-US regulatory
|
LungCure™ CDx